APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inclusion Body Myositis

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Inclusion Body Myositis Industry Growth and Trends Forecast to 2032

19 December 202591 pages

Choose your research edition.

Industry ResearchInclusion Body Myositis Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Inclusion Body Myositis Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Inclusion Body Myositis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inclusion Body Myositis Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Inclusion Body Myositis Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Inclusion Body Myositis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Inclusion Body Myositis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Inclusion Body Myositis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inclusion Body Myositis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inclusion Body Myositis include Acceleron Pharma Inc, KPI Therapeutics Inc, Milo Biotechnology LLC, Nobelpharma Co Ltd, Orphazyme ApS and Ultragenyx Pharmaceutical Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Inclusion Body Myositis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inclusion Body Myositis market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inclusion Body Myositis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inclusion Body Myositis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Inclusion Body Myositis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inclusion Body Myositis Market by Company

Acceleron Pharma Inc

KPI Therapeutics Inc

Milo Biotechnology LLC

Nobelpharma Co Ltd

Orphazyme ApS

Ultragenyx Pharmaceutical Inc

Inclusion Body Myositis Segment by Type

ACE-083

Aceneuramic Acid ER

UX-007

UX-001P

ALZ-1903

Others

Inclusion Body Myositis Segment by Application

Research Center

Hospital

Clinic

Inclusion Body Myositis Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inclusion Body Myositis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inclusion Body Myositis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inclusion Body Myositis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inclusion Body Myositis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Inclusion Body Myositis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ACE-083 Table 2. Major Company of Aceneuramic Acid ER Table 3. Major Company of UX-007 Table 4. Major Company of UX-001P Table 5. Major Company of ALZ-1903 Table 6. Major Company of Others Table 7. Global Inclusion Body Myositis Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Inclusion Body Myositis Sales by Type (2021-2026) & (K Units) Table 9. Global Inclusion Body Myositis Sales Market Share in Volume by Type (2021-2026) Table 10. Global Inclusion Body Myositis Sales by Type (2021-2026) & (US$ Million) Table 11. Global Inclusion Body Myositis Sales Market Share in Value by Type (2021-2026) Table 12. Global Inclusion Body Myositis Price by Type (2021-2026) & (US$/Unit) Table 13. Global Inclusion Body Myositis Sales by Type (2027-2032) & (K Units) Table 14. Global Inclusion Body Myositis Sales Market Share in Volume by Type (2027-2032) Table 15. Global Inclusion Body Myositis Sales by Type (2027-2032) & (US$ Million) Table 16. Global Inclusion Body Myositis Sales Market Share in Value by Type (2027-2032) Table 17. Global Inclusion Body Myositis Price by Type (2027-2032) & (US$/Unit) Table 18. North America Inclusion Body Myositis Sales by Type (2021-2026) & (K Units) Table 19. North America Inclusion Body Myositis Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Inclusion Body Myositis Sales by Type (2021-2026) & (K Units) Table 21. Europe Inclusion Body Myositis Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Inclusion Body Myositis Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Inclusion Body Myositis Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Inclusion Body Myositis Sales by Type (2021-2026) & (K Units) Table 25. Latin America Inclusion Body Myositis Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Inclusion Body Myositis Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Inclusion Body Myositis Sales by Type (2021-2026) & (US$ Million) Table 28. Inclusion Body Myositis Industry Trends Table 29. Inclusion Body Myositis Industry Drivers Table 30. Inclusion Body Myositis Industry Opportunities and Challenges Table 31. Inclusion Body Myositis Industry Restraints Table 32. Global Inclusion Body Myositis Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Inclusion Body Myositis Revenue Market Share by Company (2021-2026) Table 34. Global Inclusion Body Myositis Sales by Company (2021-2026) & (K Units) Table 35. Global Inclusion Body Myositis Sales Share by Company (2021-2026) Table 36. Global Inclusion Body Myositis Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Inclusion Body Myositis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Inclusion Body Myositis Major Company Production Sites and Headquarters Table 39. Global Inclusion Body Myositis Company, Product Type & Application Table 40. Global Inclusion Body Myositis Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Inclusion Body Myositis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Inclusion Body Myositis Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Inclusion Body Myositis Sales by Region (2021-2026) & (K Units) Table 45. Global Inclusion Body Myositis Sales Market Share in Volume by Region (2021-2026) Table 46. Global Inclusion Body Myositis Sales by Region (2021-2026) & (US$ Million) Table 47. Global Inclusion Body Myositis Sales Market Share in Value by Region (2021-2026) Table 48. Global Inclusion Body Myositis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Inclusion Body Myositis Sales by Region (2027-2032) & (K Units) Table 50. Global Inclusion Body Myositis Sales Market Share in Volume by Region (2027-2032) Table 51. Global Inclusion Body Myositis Sales by Region (2027-2032) & (US$ Million) Table 52. Global Inclusion Body Myositis Sales Market Share in Value by Region (2027-2032) Table 53. Global Inclusion Body Myositis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Inclusion Body Myositis Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Inclusion Body Myositis Sales by Application (2021-2026) & (K Units) Table 56. Global Inclusion Body Myositis Sales Market Share in Volume by Application (2021-2026) Table 57. Global Inclusion Body Myositis Sales by Application (2021-2026) & (US$ Million) Table 58. Global Inclusion Body Myositis Sales Market Share in Value by Application (2021-2026) Table 59. Global Inclusion Body Myositis Price by Application (2021-2026) & (US$/Unit) Table 60. Global Inclusion Body Myositis Sales by Application (2027-2032) & (K Units) Table 61. Global Inclusion Body Myositis Sales Market Share in Volume by Application (2027-2032) Table 62. Global Inclusion Body Myositis Sales by Application (2027-2032) & (US$ Million) Table 63. Global Inclusion Body Myositis Sales Market Share in Value by Application (2027-2032) Table 64. Global Inclusion Body Myositis Price by Application (2027-2032) & (US$/Unit) Table 65. North America Inclusion Body Myositis Sales by Application (2021-2026) & (K Units) Table 66. North America Inclusion Body Myositis Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Inclusion Body Myositis Sales by Application (2021-2026) & (K Units) Table 68. Europe Inclusion Body Myositis Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Inclusion Body Myositis Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Inclusion Body Myositis Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Inclusion Body Myositis Sales by Application (2021-2026) & (K Units) Table 72. Latin America Inclusion Body Myositis Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Inclusion Body Myositis Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Inclusion Body Myositis Sales by Application (2021-2026) & (US$ Million) Table 75. Acceleron Pharma Inc Company Information Table 76. Acceleron Pharma Inc Business Overview Table 77. Acceleron Pharma Inc Inclusion Body Myositis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Acceleron Pharma Inc Inclusion Body Myositis Product Portfolio Table 79. Acceleron Pharma Inc Recent Development Table 80. KPI Therapeutics Inc Company Information Table 81. KPI Therapeutics Inc Business Overview Table 82. KPI Therapeutics Inc Inclusion Body Myositis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. KPI Therapeutics Inc Inclusion Body Myositis Product Portfolio Table 84. KPI Therapeutics Inc Recent Development Table 85. Milo Biotechnology LLC Company Information Table 86. Milo Biotechnology LLC Business Overview Table 87. Milo Biotechnology LLC Inclusion Body Myositis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Milo Biotechnology LLC Inclusion Body Myositis Product Portfolio Table 89. Milo Biotechnology LLC Recent Development Table 90. Nobelpharma Co Ltd Company Information Table 91. Nobelpharma Co Ltd Business Overview Table 92. Nobelpharma Co Ltd Inclusion Body Myositis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Nobelpharma Co Ltd Inclusion Body Myositis Product Portfolio Table 94. Nobelpharma Co Ltd Recent Development Table 95. Orphazyme ApS Company Information Table 96. Orphazyme ApS Business Overview Table 97. Orphazyme ApS Inclusion Body Myositis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Orphazyme ApS Inclusion Body Myositis Product Portfolio Table 99. Orphazyme ApS Recent Development Table 100. Ultragenyx Pharmaceutical Inc Company Information Table 101. Ultragenyx Pharmaceutical Inc Business Overview Table 102. Ultragenyx Pharmaceutical Inc Inclusion Body Myositis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Ultragenyx Pharmaceutical Inc Inclusion Body Myositis Product Portfolio Table 104. Ultragenyx Pharmaceutical Inc Recent Development Table 105. North America Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 106. North America Inclusion Body Myositis Sales by Country (2021-2026) & (K Units) Table 107. North America Inclusion Body Myositis Sales Market Share by Country (2021-2026) Table 108. North America Inclusion Body Myositis Sales Forecast by Country (2027-2032) & (K Units) Table 109. North America Inclusion Body Myositis Sales Market Share Forecast by Country (2027-2032) Table 110. North America Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 111. North America Inclusion Body Myositis Market Size by Country (2021-2026) & (US$ Million) Table 112. North America Inclusion Body Myositis Market Share by Country (2021-2026) Table 113. North America Inclusion Body Myositis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 114. North America Inclusion Body Myositis Market Share Forecast by Country (2027-2032) Table 115. Europe Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 116. Europe Inclusion Body Myositis Sales by Country (2021-2026) & (K Units) Table 117. Europe Inclusion Body Myositis Sales Market Share by Country (2021-2026) Table 118. Europe Inclusion Body Myositis Sales Forecast by Country (2027-2032) & (K Units) Table 119. Europe Inclusion Body Myositis Sales Market Share Forecast by Country (2027-2032) Table 120. Europe Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. Europe Inclusion Body Myositis Market Size by Country (2021-2026) & (US$ Million) Table 122. Europe Inclusion Body Myositis Market Share by Country (2021-2026) Table 123. Europe Inclusion Body Myositis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. Europe Inclusion Body Myositis Market Share Forecast by Country (2027-2032) Table 125. Asia-Pacific Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. Asia-Pacific Inclusion Body Myositis Sales by Country (2021-2026) & (K Units) Table 127. Asia-Pacific Inclusion Body Myositis Sales Market Share by Country (2021-2026) Table 128. Asia-Pacific Inclusion Body Myositis Sales Forecast by Country (2027-2032) & (K Units) Table 129. Asia-Pacific Inclusion Body Myositis Sales Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Inclusion Body Myositis Market Size by Country (2021-2026) & (US$ Million) Table 132. Asia-Pacific Inclusion Body Myositis Market Share by Country (2021-2026) Table 133. Asia-Pacific Inclusion Body Myositis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Asia-Pacific Inclusion Body Myositis Market Share Forecast by Country (2027-2032) Table 135. Latin America Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Latin America Inclusion Body Myositis Sales by Country (2021-2026) & (K Units) Table 137. Latin America Inclusion Body Myositis Sales Market Share by Country (2021-2026) Table 138. Latin America Inclusion Body Myositis Sales Forecast by Country (2027-2032) & (K Units) Table 139. Latin America Inclusion Body Myositis Sales Market Share Forecast by Country (2027-2032) Table 140. Latin America Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Latin America Inclusion Body Myositis Market Size by Country (2021-2026) & (US$ Million) Table 142. Latin America Inclusion Body Myositis Market Share by Country (2021-2026) Table 143. Latin America Inclusion Body Myositis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Latin America Inclusion Body Myositis Market Share Forecast by Country (2027-2032) Table 145. Middle East and Africa Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Middle East and Africa Inclusion Body Myositis Sales by Country (2021-2026) & (K Units) Table 147. Middle East and Africa Inclusion Body Myositis Sales Market Share by Country (2021-2026) Table 148. Middle East and Africa Inclusion Body Myositis Sales Forecast by Country (2027-2032) & (K Units) Table 149. Middle East and Africa Inclusion Body Myositis Sales Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Inclusion Body Myositis Market Size by Country (2021-2026) & (US$ Million) Table 152. Middle East and Africa Inclusion Body Myositis Market Share by Country (2021-2026) Table 153. Middle East and Africa Inclusion Body Myositis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Middle East and Africa Inclusion Body Myositis Market Share Forecast by Country (2027-2032) Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Inclusion Body Myositis Distributors List Table 158. Inclusion Body Myositis Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Inclusion Body Myositis Image Figure 2. Global Inclusion Body Myositis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inclusion Body Myositis Market Size (2021-2032) & (US$ Million) Figure 4. Global Inclusion Body Myositis Sales (2021-2032) & (K Units) Figure 5. ACE-083 Image Figure 6. Global ACE-083 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Aceneuramic Acid ER Image Figure 8. Global Aceneuramic Acid ER Sales YoY Growth (2021-2032) & (K Units) Figure 9. UX-007 Image Figure 10. Global UX-007 Sales YoY Growth (2021-2032) & (K Units) Figure 11. UX-001P Image Figure 12. Global UX-001P Sales YoY Growth (2021-2032) & (K Units) Figure 13. ALZ-1903 Image Figure 14. Global ALZ-1903 Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Inclusion Body Myositis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Inclusion Body Myositis Market Share by Type 2025 VS 2032 Figure 19. North America Inclusion Body Myositis Sales Market Share in Volume by Type in 2025 Figure 20. North America Inclusion Body Myositis Sales Market Share in Value by Type in 2025 Figure 21. Europe Inclusion Body Myositis Sales Market Share in Volume by Type in 2025 Figure 22. Europe Inclusion Body Myositis Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Inclusion Body Myositis Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Inclusion Body Myositis Sales Market Share in Value by Type in 2025 Figure 25. Latin America Inclusion Body Myositis Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Inclusion Body Myositis Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Inclusion Body Myositis Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Inclusion Body Myositis Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Inclusion Body Myositis Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Research Center Image Figure 32. Global Research Center Sales YoY Growth (2021-2032) & (K Units) Figure 33. Hospital Image Figure 34. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 35. Clinic Image Figure 36. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Inclusion Body Myositis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Inclusion Body Myositis Market Share by Application 2025 VS 2032 Figure 39. North America Inclusion Body Myositis Sales Market Share in Volume by Application in 2025 Figure 40. North America Inclusion Body Myositis Sales Market Share in Value by Application in 2025 Figure 41. Europe Inclusion Body Myositis Sales Market Share in Volume by Application in 2025 Figure 42. Europe Inclusion Body Myositis Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Inclusion Body Myositis Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Inclusion Body Myositis Sales Market Share in Value by Application in 2025 Figure 45. Latin America Inclusion Body Myositis Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Inclusion Body Myositis Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Inclusion Body Myositis Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Inclusion Body Myositis Sales Market Share in Value by Application in 2025 Figure 49. North America Inclusion Body Myositis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Inclusion Body Myositis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Inclusion Body Myositis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Inclusion Body Myositis Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Inclusion Body Myositis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Inclusion Body Myositis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Inclusion Body Myositis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Inclusion Body Myositis Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Inclusion Body Myositis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Inclusion Body Myositis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Inclusion Body Myositis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Inclusion Body Myositis Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Inclusion Body Myositis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Inclusion Body Myositis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Inclusion Body Myositis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Inclusion Body Myositis Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Inclusion Body Myositis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Inclusion Body Myositis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Inclusion Body Myositis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Inclusion Body Myositis Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Inclusion Body Myositis Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Inclusion Body Myositis Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • ACE-083
  • Aceneuramic Acid ER
  • UX-007
  • UX-001P
  • ALZ-1903
  • Others
Applications
  • Research Center
  • Hospital
  • Clinic
Companies covered
  • Acceleron Pharma Inc
  • KPI Therapeutics Inc
  • Milo Biotechnology LLC
  • Nobelpharma Co Ltd
  • Orphazyme ApS
  • Ultragenyx Pharmaceutical Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inclusion Body Myositis Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Inclusion Body Myositis Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Inclusion Body Myositis Market by Type
  6. 1.3.1 ACE-083
  7. 1.3.2 Aceneuramic Acid ER
  8. 1.3.3 UX-007
  9. 1.3.4 UX-001P
  10. 1.3.5 ALZ-1903
  11. 1.3.6 Others
  12. 1.4 Global Inclusion Body Myositis Market Size by Type
  13. 1.4.1 Global Inclusion Body Myositis Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Inclusion Body Myositis Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Inclusion Body Myositis Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Inclusion Body Myositis Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Inclusion Body Myositis Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Inclusion Body Myositis Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Inclusion Body Myositis Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Inclusion Body Myositis Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Inclusion Body Myositis Industry Trends
  2. 2.2 Inclusion Body Myositis Industry Drivers
  3. 2.3 Inclusion Body Myositis Industry Opportunities and Challenges
  4. 2.4 Inclusion Body Myositis Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Inclusion Body Myositis Revenue (2021-2026)
  2. 3.2 Global Top Players by Inclusion Body Myositis Sales (2021-2026)
  3. 3.3 Global Top Players by Inclusion Body Myositis Price (2021-2026)
  4. 3.4 Global Inclusion Body Myositis Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inclusion Body Myositis Major Company Production Sites & Headquarters
  6. 3.6 Global Inclusion Body Myositis Company, Product Type & Application
  7. 3.7 Global Inclusion Body Myositis Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inclusion Body Myositis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inclusion Body Myositis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inclusion Body Myositis Tier 1, Tier 2, and Tier 3
4 Inclusion Body Myositis Regional Status and Outlook
  1. 4.1 Global Inclusion Body Myositis Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Inclusion Body Myositis Historic Market Size by Region
  3. 4.2.1 Global Inclusion Body Myositis Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Inclusion Body Myositis Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Inclusion Body Myositis Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Inclusion Body Myositis Forecasted Market Size by Region
  7. 4.3.1 Global Inclusion Body Myositis Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Inclusion Body Myositis Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Inclusion Body Myositis Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inclusion Body Myositis by Application
  1. 5.1 Inclusion Body Myositis Market by Application
  2. 5.1.1 Research Center
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Inclusion Body Myositis Market Size by Application
  6. 5.2.1 Global Inclusion Body Myositis Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Inclusion Body Myositis Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Inclusion Body Myositis Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Inclusion Body Myositis Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Inclusion Body Myositis Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Inclusion Body Myositis Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Inclusion Body Myositis Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Inclusion Body Myositis Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Acceleron Pharma Inc
  2. 6.1.1 Acceleron Pharma Inc Company Information
  3. 6.1.2 Acceleron Pharma Inc Business Overview
  4. 6.1.3 Acceleron Pharma Inc Inclusion Body Myositis Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Acceleron Pharma Inc Inclusion Body Myositis Product Portfolio
  6. 6.1.5 Acceleron Pharma Inc Recent Developments
  7. 6.2 KPI Therapeutics Inc
  8. 6.2.1 KPI Therapeutics Inc Company Information
  9. 6.2.2 KPI Therapeutics Inc Business Overview
  10. 6.2.3 KPI Therapeutics Inc Inclusion Body Myositis Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 KPI Therapeutics Inc Inclusion Body Myositis Product Portfolio
  12. 6.2.5 KPI Therapeutics Inc Recent Developments
  13. 6.3 Milo Biotechnology LLC
  14. 6.3.1 Milo Biotechnology LLC Company Information
  15. 6.3.2 Milo Biotechnology LLC Business Overview
  16. 6.3.3 Milo Biotechnology LLC Inclusion Body Myositis Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Milo Biotechnology LLC Inclusion Body Myositis Product Portfolio
  18. 6.3.5 Milo Biotechnology LLC Recent Developments
  19. 6.4 Nobelpharma Co Ltd
  20. 6.4.1 Nobelpharma Co Ltd Company Information
  21. 6.4.2 Nobelpharma Co Ltd Business Overview
  22. 6.4.3 Nobelpharma Co Ltd Inclusion Body Myositis Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nobelpharma Co Ltd Inclusion Body Myositis Product Portfolio
  24. 6.4.5 Nobelpharma Co Ltd Recent Developments
  25. 6.5 Orphazyme ApS
  26. 6.5.1 Orphazyme ApS Company Information
  27. 6.5.2 Orphazyme ApS Business Overview
  28. 6.5.3 Orphazyme ApS Inclusion Body Myositis Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Orphazyme ApS Inclusion Body Myositis Product Portfolio
  30. 6.5.5 Orphazyme ApS Recent Developments
  31. 6.6 Ultragenyx Pharmaceutical Inc
  32. 6.6.1 Ultragenyx Pharmaceutical Inc Company Information
  33. 6.6.2 Ultragenyx Pharmaceutical Inc Business Overview
  34. 6.6.3 Ultragenyx Pharmaceutical Inc Inclusion Body Myositis Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ultragenyx Pharmaceutical Inc Inclusion Body Myositis Product Portfolio
  36. 6.6.5 Ultragenyx Pharmaceutical Inc Recent Developments
7 North America by Country
  1. 7.1 North America Inclusion Body Myositis Sales by Country
  2. 7.1.1 North America Inclusion Body Myositis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Inclusion Body Myositis Sales by Country (2021-2026)
  4. 7.1.3 North America Inclusion Body Myositis Sales Forecast by Country (2027-2032)
  5. 7.2 North America Inclusion Body Myositis Market Size by Country
  6. 7.2.1 North America Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Inclusion Body Myositis Market Size by Country (2021-2026)
  8. 7.2.3 North America Inclusion Body Myositis Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Inclusion Body Myositis Sales by Country
  2. 8.1.1 Europe Inclusion Body Myositis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Inclusion Body Myositis Sales by Country (2021-2026)
  4. 8.1.3 Europe Inclusion Body Myositis Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Inclusion Body Myositis Market Size by Country
  6. 8.2.1 Europe Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Inclusion Body Myositis Market Size by Country (2021-2026)
  8. 8.2.3 Europe Inclusion Body Myositis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Inclusion Body Myositis Sales by Country
  2. 9.1.1 Asia-Pacific Inclusion Body Myositis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Inclusion Body Myositis Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Inclusion Body Myositis Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Inclusion Body Myositis Market Size by Country
  6. 9.2.1 Asia-Pacific Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Inclusion Body Myositis Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Inclusion Body Myositis Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Inclusion Body Myositis Sales by Country
  2. 10.1.1 South America Inclusion Body Myositis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Inclusion Body Myositis Sales by Country (2021-2026)
  4. 10.1.3 South America Inclusion Body Myositis Sales Forecast by Country (2027-2032)
  5. 10.2 South America Inclusion Body Myositis Market Size by Country
  6. 10.2.1 South America Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Inclusion Body Myositis Market Size by Country (2021-2026)
  8. 10.2.3 South America Inclusion Body Myositis Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Inclusion Body Myositis Sales by Country
  2. 11.1.1 Middle East and Africa Inclusion Body Myositis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Inclusion Body Myositis Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Inclusion Body Myositis Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Inclusion Body Myositis Market Size by Country
  6. 11.2.1 Middle East and Africa Inclusion Body Myositis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Inclusion Body Myositis Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Inclusion Body Myositis Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Inclusion Body Myositis Value Chain Analysis
  2. 12.1.1 Inclusion Body Myositis Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Inclusion Body Myositis Production Mode & Process
  7. 12.2 Inclusion Body Myositis Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Inclusion Body Myositis Distributors
  10. 12.2.3 Inclusion Body Myositis Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst